Immunohistochemical prognostic criteria in xeroderma pigmentosum.
Karakok
Metin
M
Department of Pathology, Gaziantep University Medical Faculty, Research and Training Hospital, Gaziantep, Turkey.
Turkmen
Arif
A
Bekerecioglu
Mehmet
M
Koçer
N Emrah
NE
D000293:Adolescent; D000328:Adult; D002280:Basal Cell Carcinoma / Q000378:metabolism* / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000378:metabolism* / Q000473:pathology; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D019394:Ki-67 Antigen / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D018809:Proliferating Cell Nuclear Antigen / Q000378:metabolism*; D012878:Skin Neoplasms / Q000378:metabolism* / Q000473:pathology; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism*; D014983:Xeroderma Pigmentosum / Q000378:metabolism* / Q000401:mortality / Q000473:pathology; D055815:Young Adult
D019394:Ki-67 Antigen; D018809:Proliferating Cell Nuclear Antigen; D016159:Tumor Suppressor Protein p53